Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine
Clinical trial NCT02501421 · COMPLETED
Trial details
- NCT number
- NCT02501421
- Sponsor
- Research Institute for Biological Safety Problems
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.